Continuous Glucose Monitor Metrics Are Associated with Emergency Department Visits and Hospitalizations for Hypoglycemia and Hyperglycemia, but Have Low Predictive Value-Reference-Cited by-同舟云学术

Continuous Glucose Monitor Metrics Are Associated with Emergency Department Visits and Hospitalizations for Hypoglycemia and Hyperglycemia, but Have Low Predictive Value

Published:2024-05-01 Issue:5 Volume:26 Page:298-306
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Gilliam Lisa K.¹^ORCID,Parker Melissa M.²,Moffet Howard H.²,Lee Alexandra K.³,Karter Andrew J.²⁴⁵^ORCID

Affiliation:

1. Kaiser Northern California Diabetes Program, Endocrinology and Internal Medicine, Kaiser Permanente, South San Francisco Medical Center, South San Francisco, California, USA.

2. Division of Research, Kaiser Permanente, Oakland, California, USA.

3. Division of Geriatrics, University of California, San Francisco, San Francisco, California, USA.

4. Department of General Internal Medicine, University of California, San Francisco, San Francisco, California, USA.

5. Department of Health Systems and Population Health, University of Washington, Seattle, Washington, USA.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2023.0493

Reference31 articles.

1. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

2. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

3. The Diabetes Control and Complications Trial (DCCT): Design and Methodologic Considerations for the Feasibility Phase

4. Sociodemographic, Clinical, and Treatment-Related Factors Associated With Hyperglycemic Crises Among Adults With Type 1 or Type 2 Diabetes in the US From 2014 to 2020

5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)